|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Investment in marketable securities | |||||||||||||||
| Accounts receivable (net of provision for credit loss) | |||||||||||||||
| Other current assets | |||||||||||||||
| Inventories | |||||||||||||||
| Total current assets | |||||||||||||||
| Long-term investments and other assets | |||||||||||||||
| Investments in affiliated companies | |||||||||||||||
| Investments in other companies in 2025 | |||||||||||||||
| Other non-current assets | |||||||||||||||
| Deferred income taxes | |||||||||||||||
| Funds in respect of employee rights upon retirement | |||||||||||||||
| Total non-current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Operating lease right of use assets, net | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Total assets | |||||||||||||||
| Current liabilities | |||||||||||||||
| Credit from banking institutions | |||||||||||||||
| Accounts payable | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Long-term liabilities | |||||||||||||||
| Deferred income taxes | |||||||||||||||
| Loan from bank institution (Note 10B) | |||||||||||||||
| Liability for employee rights upon retirement | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Operating lease liabilities, non-current | |||||||||||||||
| Other non-current liabilities | |||||||||||||||
| Total non-current liabilities | |||||||||||||||
| Equity: | |||||||||||||||
| Stockholders' equity | |||||||||||||||
| Share capital – ordinary shares of NIS 0.33 par value: 1,983 1,983 Authorized – December 31, 2025 and 2024 – 60,000,000 shares Issued and outstanding – December 31, 2025 and 2024 – 23,475,431 shares | |||||||||||||||
| Additional paid- in capital | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Retained earnings | |||||||||||||||
| Treasury stock at cost – December 31, 2025 – 3,666,789. December 31, 2024 – 3,581,851 shares | |||||||||||||||
| Stockholders’ equity | |||||||||||||||
| Non-controlling interests | |||||||||||||||
| Total equity | |||||||||||||||
| Total liabilities and equity | |||||||||||||||
Loading...